In order to identify more druggable targets for obesity-associated IDD, it would be interesting to delineate if JAK2/STAT3 signaling is also involved in leptin-induced ADAMTS-4/5 upregulation and aggrecan downregulation. Here, ACAN is linked to obesity disorder.